GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bcl2l1 | affects splicing | EXP | | 6480464 | CTD | Thapsigargin affects the splicing of BCL2L1 mRNA | PMID:25762722 | Bcl2l1 | increases expression | EXP | | 6480464 | CTD | Thapsigargin results in increased expression of BCL2L1 protein | PMID:25762722 | Bcl2l1 | multiple interactions | EXP | | 6480464 | CTD | 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Thapsigargin affects the splicing of BCL2L1 mRNA]; GW 4869 inhibits the reaction [Thapsigargin affects the splicing of BCL2L1 mRNA]; PLA2G6 mutant form inhibits the reaction [Thapsigargin affects the splicing of BCL2L1 mRNA] | PMID:25762722 | Bcl2l1 | affects splicing | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | Thapsigargin affects the splicing of BCL2L1 mRNA | PMID:25762722 | Bcl2l1 | decreases expression | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | Thapsigargin results in decreased expression of BCL2L1 protein | PMID:30841431 | Bcl2l1 | multiple interactions | ISO | Bcl2l1 (Mus musculus) | 6480464 | CTD | 4-(3-3,4-p-menthadien-(1,8)-yl)olivetol inhibits the reaction [Thapsigargin results in decreased expression of BCL2L1 protein]; O-1602 compound inhibits the reaction [Thapsigargin results in decreased expression of BCL2L1 protein] | PMID:30841431 | Bcl2l1 | multiple interactions | ISO | BCL2L1 (Homo sapiens) | 6480464 | CTD | BCL2L1 protein inhibits the reaction [Thapsigargin results in increased expression of ERN1 protein]; BCL2L1 protein inhibits the reaction [Thapsigargin results in increased expression of XBP1 protein alternative form] | PMID:23885834 | |
Go Back to source page | Continue to Ontology report |